Neogen Chemicals Limited (NEOGEN.NS)
INR 2189.0
(-1.8%)
INR 2189.0
(-1.8%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 6.9 Billion | 6.86 Billion | 4.87 Billion | 3.36 Billion | 3.06 Billion | 2.39 Billion |
| Cost of Revenue | 4.04 Billion | 3.88 Billion | 3.47 Billion | 2.39 Billion | 2.17 Billion | 1.7 Billion |
| Gross Profit | 2.86 Billion | 2.97 Billion | 1.39 Billion | 969.85 Million | 881.39 Million | 681.76 Million |
| Operating Expenses | 2.28 Billion | 2.02 Billion | 651.6 Million | 395.29 Million | 353.28 Million | 271.8 Million |
| Selling, General and Administrative Expenses | 304.6 Million | 287.5 Million | 219.7 Million | 125.52 Million | 128.39 Million | 131.88 Million |
| Research and Development Expenses | 34.9 Million | 56.6 Million | 47 Million | 29.37 Million | 20.41 Million | 14.01 Million |
| Other Expenses | 1.94 Billion | 44.5 Million | 1.3 Million | 16 Thousand | 15 Thousand | 1.85 Million |
| Cost and Expenses | 6.03 Billion | 5.9 Billion | 4.12 Billion | 2.78 Billion | 2.53 Billion | 1.98 Billion |
| Operating Income | 871.8 Million | 999.7 Million | 228.3 Million | 574.56 Million | 528.1 Million | 409.96 Million |
| Interest Expense | 420.6 Million | 289.4 Million | 178 Million | 129.33 Million | 109.56 Million | 112.47 Million |
| Income Tax Expense | 171.2 Million | 210.6 Million | 124.4 Million | 128.84 Million | 124.4 Million | 83.07 Million |
| Earnings before Tax | 525.9 Million | 710.3 Million | 570.1 Million | 442.15 Million | 410.96 Million | 292.54 Million |
| Net Income | 356.5 Million | 499.7 Million | 446.3 Million | 313.3 Million | 286.56 Million | 209.46 Million |
| Earnings Per Share Basic | 13.96 | 20.04 | 17.90 | 13.43 | 12.28 | 10.43 |
| Earnings Per Share Diluted | 13.96 | 20.04 | 17.90 | 13.43 | 12.28 | 10.43 |
| Weighted Average Shares Outstanding | 25.53 Million | 24.93 Million | 24.93 Million | 23.33 Million | 23.33 Million | 20.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.53 Million | 24.93 Million | 24.93 Million | 23.33 Million | 23.33 Million | 20.07 Million |
| Gross Margin | 0.41 | 0.43 | 0.29 | 0.29 | 0.29 | 0.29 |
| EBIT Margin | 0.17 | 0.17 | 0.18 | 0.19 | 0.19 | 0.18 |
| Profit Margin | 0.05 | 0.07 | 0.09 | 0.09 | 0.09 | 0.09 |
| EBITDA | 1.17 Billion | 1.16 Billion | 876.6 Million | 644.96 Million | 582.63 Million | 440.28 Million |
| Earnings Before Tax Margin | 0.13 | 0.15 | 0.05 | 0.17 | 0.17 | 0.17 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.79 Billion | 6.9 Billion | 1.99 Billion | 1.64 Billion | 1.61 Billion | 1.64 Billion |
| Cost of Revenue | 1.19 Billion | 4.67 Billion | 1.32 Billion | 909.8 Million | 875.8 Million | 918.5 Million |
| Gross Profit | 607.5 Million | 2.23 Billion | 669.5 Million | 734.6 Million | 741.3 Million | 730.3 Million |
| Operating Expenses | 367.6 Million | 1.36 Billion | 370.2 Million | 589.1 Million | 540 Million | 504.5 Million |
| Selling, General and Administrative Expenses | 367.6 Million | - | 370.2 Million | 364.4 Million | 306.1 Million | 320.6 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 15.7 Million | 74.7 Million | 22.1 Million | 15.8 Million | 18.9 Million | 17.9 Million |
| Cost and Expenses | 1.55 Billion | 6.03 Billion | 1.69 Billion | 1.49 Billion | 1.41 Billion | 1.42 Billion |
| Operating Income | 239.9 Million | 871.8 Million | 299.3 Million | 162.2 Million | 220.7 Million | 243.9 Million |
| Interest Expense | 98.2 Million | 429.6 Million | 105.9 Million | 105.2 Million | 110.9 Million | 107.6 Million |
| Income Tax Expense | 42.9 Million | 171.2 Million | 55.4 Million | 46.4 Million | 30.6 Million | 38.8 Million |
| Earnings before Tax | 157.4 Million | 525.9 Million | 224.5 Million | 57 Million | 109.8 Million | 136.3 Million |
| Net Income | 114.7 Million | 356.5 Million | 169.3 Million | 10.6 Million | 79.2 Million | 97.5 Million |
| Earnings Per Share Basic | 4.35 | - | 6.42 | 0.41 | 3.18 | 3.91 |
| Earnings Per Share Diluted | 4.35 | - | 6.42 | 0.41 | 3.18 | 3.91 |
| Weighted Average Shares Outstanding | 26.38 Million | 25.53 Million | 26.37 Million | 25.85 Million | 24.93 Million | 24.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.38 Million | 25.53 Million | 26.37 Million | 25.85 Million | 24.93 Million | 24.93 Million |
| Gross Margin | 0.34 | 0.32 | 0.34 | 0.45 | 0.46 | 0.44 |
| EBIT Margin | 0.17 | - | 0.18 | 0.13 | 0.17 | 0.18 |
| Profit Margin | 0.06 | 0.05 | 0.08 | 0.01 | 0.05 | 0.06 |
| EBITDA | 308 Million | - | 357.9 Million | 219.6 Million | 278.6 Million | 298.7 Million |
| Earnings Before Tax Margin | 0.13 | 0.13 | 0.15 | 0.10 | 0.14 | 0.15 |
BNGRF
002630
AKVA
SR
CRJ
600754